Stocksigma LogoStocksigma Logo

Piramal Pharma Secures Improved NSE ESG Rating of 65 for FY26

On 3rd Sep'26, Piramal Pharma disclosed an upgraded ESG rating of 65 for FY26, assigned voluntarily by NSE Sustainability Ratings and Analytics

Piramal Pharma Secures Improved NSE ESG Rating of 65 for FY26

Piramal Pharma Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 7:58 pm

Piramal Pharma Secures Improved NSE ESG Rating of 65 for FY26 On 3rd Sep'26, Piramal Pharma disclosed an upgraded ESG rating of 65 for FY26, assigned voluntarily by NSE Sustainability Ratings and Analytics. This reflects a marginal improvement from the previous score of 64. The rating was independently prepared using public domain data without formal engagement by the company. The slight upward revision highlights Piramal Pharma's incremental progress in sustainable and responsible corporate operations.

Original exchange filing (PDF)

More announcements from Piramal Pharma Ltd

All Piramal Pharma Ltd announcements